Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells

Aims. Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) have become a promising tool in cardiovascular safety pharmacology. Immaturity of iPS-CMs remains an ongoing concern. We compared electrophysiological and contractile features of cardiac bodies (hiPS-CBs) derived from human-induced...

Full description

Saved in:
Bibliographic Details
Main Authors: Jan Trieschmann, Moritz Haustein, Annette Köster, Jürgen Hescheler, Konrad Brockmeier, Gerardus Bennink, Tobias Hannes
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2019/6096294
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567145134817280
author Jan Trieschmann
Moritz Haustein
Annette Köster
Jürgen Hescheler
Konrad Brockmeier
Gerardus Bennink
Tobias Hannes
author_facet Jan Trieschmann
Moritz Haustein
Annette Köster
Jürgen Hescheler
Konrad Brockmeier
Gerardus Bennink
Tobias Hannes
author_sort Jan Trieschmann
collection DOAJ
description Aims. Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) have become a promising tool in cardiovascular safety pharmacology. Immaturity of iPS-CMs remains an ongoing concern. We compared electrophysiological and contractile features of cardiac bodies (hiPS-CBs) derived from human-induced pluripotent stem cells and human neonatal and infantile myocardial slices relevant for drug screening. Methods and Results. Myocardial tissue slices were prepared from biopsies obtained from patients undergoing surgery for hypoplastic left heart syndrome (HLHS) and tetralogy of Fallot (TOF). Electrophysiological features and response to Ik,r blockade as well as contractile properties were investigated using microelectrodes and isometric force measurements and were compared to hiPS-CBs. Both native myocardial tissue slices as well as hiPS-CBs showed action potential prolongation after Ik,r blockade, but early afterdepolarisations could be observed in native myocardial tissue slices only. The force-frequency relationship (FFR) varied at lower frequencies and was negative throughout at higher frequencies in hiPS-CBs. In contrast, native myocardial tissue slices exhibited positive, negative, and biphasic FFRs. In contrast to native myocardial tissue slices, hiPS-CBs failed to show an inotropic response to ß-adrenergic stimulation. Although all groups showed ß-adrenergic induced positive lusitropy, the effect was more pronounced in myocardial tissue slices. Conclusion. hiPS-CBs were able to reproduce AP prolongation after Ik,r blockade, but to a lesser extent compared to human neonatal and infantile myocardial tissue slices. Early afterdepolarisations could not be induced in hiPS-CBs. Contractile force was differently regulated by β-adrenergic stimulation in hiPS-CBs and the native myocardium. If used for cardiotoxicity screening, caution is warranted as hiPS-CBs might be less sensitive to pharmacologic targets compared to the native myocardium of neonates and infants.
format Article
id doaj-art-0f4a6a369307477087dddc35e4f25eb6
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-0f4a6a369307477087dddc35e4f25eb62025-02-03T01:02:16ZengWileyStem Cells International1687-966X1687-96782019-01-01201910.1155/2019/60962946096294Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem CellsJan Trieschmann0Moritz Haustein1Annette Köster2Jürgen Hescheler3Konrad Brockmeier4Gerardus Bennink5Tobias Hannes6Department of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Kerpener Str. 52, 50924 Cologne, GermanyDepartment of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Kerpener Str. 52, 50924 Cologne, GermanyInstitute for Neurophysiology, University of Cologne, Robert-Koch-Str. 39, 50931 Cologne, GermanyInstitute for Neurophysiology, University of Cologne, Robert-Koch-Str. 39, 50931 Cologne, GermanyDepartment of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Kerpener Str. 52, 50924 Cologne, GermanyCardiothoracic Surgery, University Hospital of Cologne, Kerpener Str. 52, 50924 Cologne, GermanyDepartment of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Kerpener Str. 52, 50924 Cologne, GermanyAims. Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) have become a promising tool in cardiovascular safety pharmacology. Immaturity of iPS-CMs remains an ongoing concern. We compared electrophysiological and contractile features of cardiac bodies (hiPS-CBs) derived from human-induced pluripotent stem cells and human neonatal and infantile myocardial slices relevant for drug screening. Methods and Results. Myocardial tissue slices were prepared from biopsies obtained from patients undergoing surgery for hypoplastic left heart syndrome (HLHS) and tetralogy of Fallot (TOF). Electrophysiological features and response to Ik,r blockade as well as contractile properties were investigated using microelectrodes and isometric force measurements and were compared to hiPS-CBs. Both native myocardial tissue slices as well as hiPS-CBs showed action potential prolongation after Ik,r blockade, but early afterdepolarisations could be observed in native myocardial tissue slices only. The force-frequency relationship (FFR) varied at lower frequencies and was negative throughout at higher frequencies in hiPS-CBs. In contrast, native myocardial tissue slices exhibited positive, negative, and biphasic FFRs. In contrast to native myocardial tissue slices, hiPS-CBs failed to show an inotropic response to ß-adrenergic stimulation. Although all groups showed ß-adrenergic induced positive lusitropy, the effect was more pronounced in myocardial tissue slices. Conclusion. hiPS-CBs were able to reproduce AP prolongation after Ik,r blockade, but to a lesser extent compared to human neonatal and infantile myocardial tissue slices. Early afterdepolarisations could not be induced in hiPS-CBs. Contractile force was differently regulated by β-adrenergic stimulation in hiPS-CBs and the native myocardium. If used for cardiotoxicity screening, caution is warranted as hiPS-CBs might be less sensitive to pharmacologic targets compared to the native myocardium of neonates and infants.http://dx.doi.org/10.1155/2019/6096294
spellingShingle Jan Trieschmann
Moritz Haustein
Annette Köster
Jürgen Hescheler
Konrad Brockmeier
Gerardus Bennink
Tobias Hannes
Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells
Stem Cells International
title Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells
title_full Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells
title_fullStr Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells
title_full_unstemmed Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells
title_short Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells
title_sort different responses to drug safety screening targets between human neonatal and infantile heart tissue and cardiac bodies derived from human induced pluripotent stem cells
url http://dx.doi.org/10.1155/2019/6096294
work_keys_str_mv AT jantrieschmann differentresponsestodrugsafetyscreeningtargetsbetweenhumanneonatalandinfantilehearttissueandcardiacbodiesderivedfromhumaninducedpluripotentstemcells
AT moritzhaustein differentresponsestodrugsafetyscreeningtargetsbetweenhumanneonatalandinfantilehearttissueandcardiacbodiesderivedfromhumaninducedpluripotentstemcells
AT annettekoster differentresponsestodrugsafetyscreeningtargetsbetweenhumanneonatalandinfantilehearttissueandcardiacbodiesderivedfromhumaninducedpluripotentstemcells
AT jurgenhescheler differentresponsestodrugsafetyscreeningtargetsbetweenhumanneonatalandinfantilehearttissueandcardiacbodiesderivedfromhumaninducedpluripotentstemcells
AT konradbrockmeier differentresponsestodrugsafetyscreeningtargetsbetweenhumanneonatalandinfantilehearttissueandcardiacbodiesderivedfromhumaninducedpluripotentstemcells
AT gerardusbennink differentresponsestodrugsafetyscreeningtargetsbetweenhumanneonatalandinfantilehearttissueandcardiacbodiesderivedfromhumaninducedpluripotentstemcells
AT tobiashannes differentresponsestodrugsafetyscreeningtargetsbetweenhumanneonatalandinfantilehearttissueandcardiacbodiesderivedfromhumaninducedpluripotentstemcells